Heart News and Research

RSS

Problem shared is a problem halved for mothers of cardiac defect babies

Posttraumatic stress, depression, and anxiety are common in pregnant women after receiving a prenatal diagnosis of congenital heart disease, say researchers.

11 Sep 2012

Durata Therapeutics completes dalbavancin Phase 3 trials on ABSSSI

Durata Therapeutics today announced results from its QT study of the company's lead product candidate, dalbavancin. Dalbavancin is currently under investigation in two ongoing, global, Phase 3 clinical trials for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

11 Sep 2012

Blood flow simulation tools can test and optimize Berlin Heart design

Structural and mechanical engineers at the University of California, San Diego, are working together to create blood flow simulations that could lead to improvements in the design of a cardiac pump for children born with heart defects. They hope that the design changes will improve young patients' outcomes.

11 Sep 2012

Half of all people of South Asian, African descent will develop diabetes by age 80

Half of all people of South Asian, African and African Caribbean descent will develop diabetes by age 80 according to a new study published today. The study is the first to reveal the full extent of ethnic differences in the risk of developing type 2 diabetes and also provides some answers as to the causes of the increased risk.

11 Sep 2012

MicroRNA-145 gene therapy can drastically reduce severity and progression of atherosclerosis

Researchers at St. Michael's Hospital are one step closer to understanding why plaque bursts in coronary arteries and causes heart attacks.

11 Sep 2012

Cardiac stem cells from newborns show stronger regenerative ability

Researchers at the University of Maryland School of Medicine, who are exploring novel ways to treat serious heart problems in children, have conducted the first direct comparison of the regenerative abilities of neonatal and adult-derived human cardiac stem cells.

11 Sep 2012

William LifeSkills program could reduce anger, blood pressure among school students

A 10-week program that fits easily into the high school curriculum could give students a lifetime of less anger and lower blood pressure, researchers report.

11 Sep 2012

CPF to kick off 'Pulmonary Fibrosis Awareness Month'

Each year around the world, as many as 48,000 people are diagnosed with pulmonary fibrosis and 40,000 people die – the same number of people who are lost to breast cancer annually. Pulmonary fibrosis is a devastating disease that robs people of their ability to breathe. To help raise awareness about this unknown deadly disease, the Coalition for Pulmonary Fibrosis (CPF) is kicking off "Pulmonary Fibrosis Awareness Month" this September.

10 Sep 2012

New molecular pathway that leads to preeclampsia identified

Preeclampsia is one of the most dangerous conditions for the expectant mother and the unborn child and is characterized by elevated blood pressure and protein in the urine in the last trimester of pregnancy.

10 Sep 2012

NIH awards Immunetics $3.7M SBIR contract for Babesia infection blood screening test

Immunetics, Inc., has received a $3.7 million, two year SBIR contract from the National Heart, Lung and Blood Institute, an agency of the National Institutes of Health (NIH), to support clinical trials of a new blood screening test for Babesia infection.

10 Sep 2012

Acute Cardiac Care Congress to be held in Istanbul, Turkey

More than 400 scientific abstracts will be presented by international scientists, providing a great source of news stories for journalists.

10 Sep 2012

Baylor Health Care System raises awareness about atrial fibrillation

An estimated 2.5 million Americans suffer from irregular heartbeats-also known as atrial fibrillation. Baylor Health Care System is raising awareness about this often misunderstood, but potentially life changing cardiovascular condition whose incidence is on the rise and expected to more than double by 2050.

10 Sep 2012

Tight blood sugar control does not benefit pediatric patients undergoing heart surgery

Although some studies have portrayed tight blood sugar control as a potential means of lowering infection rates in critically ill adults, a new study-led by principal investigator Michael Agus, MD, director of the Medicine Critical Care Program at Boston Children's Hospital-found no indication that the approach benefits pediatric patients undergoing heart surgery.

10 Sep 2012

Cedars-Sinai receives CIRM grant to continue study of stem cell therapy for heart disease

A team of Cedars-Sinai Heart Institute stem cell researchers today was awarded a $1.3 million grant from the California Institute of Regenerative Medicine to continue study of an experimental stem cell therapy that treats heart attack patients with heart-derived cells. Earlier this year, data from the first clinical trial of the stem cell treatment showed the therapy helped damaged hearts regrow healthy muscle.

10 Sep 2012

Increased risk of heart failure and cardiovascular death linked to thickening of heart's right ventricle

Researchers at the Perelman School of Medicine at the University of Pennsylvania report in a new study that thickening of the heart's right ventricle is associated with an increased risk of heart failure and cardiovascular death in patients without clinical cardiovascular disease at baseline. The study is published online ahead of print in the journal Circulation.

7 Sep 2012

Health law among Obama's accomplishments as he makes case for second term

During the final night of the Democratic convention, President Barack Obama and Vice President Joe Biden pledged to protect Medicare from GOP proposals to turn it into what they called a voucher program and extolled the benefits of the health law.

7 Sep 2012

Trevena to present TRV027 Phase 1 clinical data at 16th Annual Heart Failure Society of America Meeting

Trevena, Inc., the leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, today announced that it is presenting a poster featuring Phase 1 clinical data on TRV027 at the 16th Annual Heart Failure Society of America Meeting being held in Seattle, WA, September 9th-12th. Trevena is developing TRV027 for the treatment of acute decompensated heart failure.

7 Sep 2012

CIRM awards Cedars-Sinai $1.3M to study stem cell therapy for heart attacks

7 Sep 2012

Test to identify potentially deadly calcium deposits in tissues and blood vessels

A new test could help identify and treat individuals at risk of developing potentially deadly calcium deposits in their tissues and blood vessels, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. Heart disease is the number one killer of patients with chronic kidney disease (CKD), and vascular calcification is thought to play a major role.

7 Sep 2012

Genetic test to help prescribe proper dose of blood-thinner warfarin

Patients suffering from dangerous blood clots will receive genetic testing to help health professionals at the University of Illinois Hospital & Health Sciences System prescribe the proper dose of the blood-thinner warfarin.

7 Sep 2012

Heart News and Research

Problem shared is a problem halved for mothers of cardiac defect babies

Durata Therapeutics completes dalbavancin Phase 3 trials on ABSSSI

Blood flow simulation tools can test and optimize Berlin Heart design

Half of all people of South Asian, African descent will develop diabetes by age 80

MicroRNA-145 gene therapy can drastically reduce severity and progression of atherosclerosis

Cardiac stem cells from newborns show stronger regenerative ability

William LifeSkills program could reduce anger, blood pressure among school students

CPF to kick off 'Pulmonary Fibrosis Awareness Month'

New molecular pathway that leads to preeclampsia identified

NIH awards Immunetics $3.7M SBIR contract for Babesia infection blood screening test

Acute Cardiac Care Congress to be held in Istanbul, Turkey

Baylor Health Care System raises awareness about atrial fibrillation

Tight blood sugar control does not benefit pediatric patients undergoing heart surgery

Cedars-Sinai receives CIRM grant to continue study of stem cell therapy for heart disease

Increased risk of heart failure and cardiovascular death linked to thickening of heart's right ventricle

Health law among Obama's accomplishments as he makes case for second term

Trevena to present TRV027 Phase 1 clinical data at 16th Annual Heart Failure Society of America Meeting

CIRM awards Cedars-Sinai $1.3M to study stem cell therapy for heart attacks

Test to identify potentially deadly calcium deposits in tissues and blood vessels

Genetic test to help prescribe proper dose of blood-thinner warfarin

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News